All In Biotech

Drug Trial Radar · NCT00841971

Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients

Anidulafungin Versus Fluconazole for the Prevention of Invasive Fungal Infections in High-risk Liver Transplant Recipients: a Randomized, Double-blind Trial

Last checked: Nov 20, 2026Latest source record: Dec 17, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

200

Actual

Start

Feb 2010

Primary completion

Jul 2013

Study completion May 2014

Sponsor

Lead sponsor
University of PittsburghAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 12, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the efficacy of anidulafungin versus fluconazole for the prevention of fungal diseases in liver transplant recipients

Conditions

  • Mycoses
  • Fungemia
  • Central Nervous System Fungal Infections
  • Lung Diseases, Fungal

Interventions

  • AnidulafunginDrug

    200 mg IV loading dose followed by 100 mg qd for 21 days

  • FluconazoleDrug

    400 mg IV for 21 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Frequency of Fungal InfectionTime frame: 90 days post enrollment

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • UCLA Medical Cente

    Los Angeles, California

  • University of Miami

    Miami, Florida

  • University of Michigan

    Ann Arbor, Michigan

  • University of Pittsburgh

    Pittsburgh, Pennsylvania

  • University of Washington Medical Center

    Seattle, Washington

  • University of Wisconsin - Madison

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.